Multiple MUC1-expressing tumors were analyzed in the study, including colon (33.5%), ovarian (27%), breast (9.5%), non-small cell lung cancer (9.5%), and pancreatic cancer (6.8%). Here, MUC1 is linked to pancreatic neoplasm.